Javascript must be enabled to continue!
Characterization of transforming growth factor‐β growth regulatory effects and receptors on bovine mammary cells
View through CrossRef
AbstractTransforming growth factor‐β (TGF‐β) has been shown to inhibit mammary morphogenesis, growth, and differentiation in murine studies. We have characterized TGF‐β receptors and their autoregulation, and the growth response to TGF‐β1 and TGF‐β2 in cultured bovine mammary epithelium (MAC‐T) and fibroblasts. Affinity labelling studies revealed that fibroblast and epithelial cells contained type I, II, and III (betaglycan) receptors, with the type III receptor being the predominant binding component. On both fibroblasts and epithelial cells, TGF‐β1 and TGF‐β2 had equal binding affinities for the type I and II receptors, but TGF‐β2 had a higher affinity for the type III receptor. Also, preincubation of MAC‐T cells with 50 pM TGF‐β1 or TGF‐β2 markedly downregulated TGF‐β receptors. Proliferative response was measured using both total DNA and 3H‐thymidine incorporation. Both TGF‐β isoforms were effective in inhibiting proliferation of MAC‐T cells and fibroblasts. Inhibition of proliferation was not altered following immortalization of fibroblasts with SV‐40 Large‐T‐antigen (LT), even when the cells acquired a transformed phenotype. Inhibition of proliferation was not a result of cytotoxicity, as TGF‐β at concentrations 1,000‐fold higher than ED50 levels did not increase cell death. Moreover, the inhibition was reversible as shown by return of cellular proliferation to control levels following TGF‐β removal. Although growth inhibition was not transient as culture of MAC‐T cells in TGF‐β resulted in sustained inhibition of proliferation for at least 144 h. © 1995 Wiley‐Liss, Inc.
Title: Characterization of transforming growth factor‐β growth regulatory effects and receptors on bovine mammary cells
Description:
AbstractTransforming growth factor‐β (TGF‐β) has been shown to inhibit mammary morphogenesis, growth, and differentiation in murine studies.
We have characterized TGF‐β receptors and their autoregulation, and the growth response to TGF‐β1 and TGF‐β2 in cultured bovine mammary epithelium (MAC‐T) and fibroblasts.
Affinity labelling studies revealed that fibroblast and epithelial cells contained type I, II, and III (betaglycan) receptors, with the type III receptor being the predominant binding component.
On both fibroblasts and epithelial cells, TGF‐β1 and TGF‐β2 had equal binding affinities for the type I and II receptors, but TGF‐β2 had a higher affinity for the type III receptor.
Also, preincubation of MAC‐T cells with 50 pM TGF‐β1 or TGF‐β2 markedly downregulated TGF‐β receptors.
Proliferative response was measured using both total DNA and 3H‐thymidine incorporation.
Both TGF‐β isoforms were effective in inhibiting proliferation of MAC‐T cells and fibroblasts.
Inhibition of proliferation was not altered following immortalization of fibroblasts with SV‐40 Large‐T‐antigen (LT), even when the cells acquired a transformed phenotype.
Inhibition of proliferation was not a result of cytotoxicity, as TGF‐β at concentrations 1,000‐fold higher than ED50 levels did not increase cell death.
Moreover, the inhibition was reversible as shown by return of cellular proliferation to control levels following TGF‐β removal.
Although growth inhibition was not transient as culture of MAC‐T cells in TGF‐β resulted in sustained inhibition of proliferation for at least 144 h.
© 1995 Wiley‐Liss, Inc.
Related Results
Investigations into the puerperium of Beagle-breed female dogs
Investigations into the puerperium of Beagle-breed female dogs
The present thesis focusses on the study of the puerperium of female dogs, with the general objective to increase available knowledge regarding the puerperium of that species and t...
Embryonic Mammary Gland Development
Embryonic Mammary Gland Development
AbstractMammary glands are derived from the ectoderm and are a defining feature of mammals. The number of glands that develop along the ‘mammary lines’ on either side of the ventra...
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
<p><em><span class="markedContent"><span style="left: calc(var(--scale-factor)*195.53px); top: calc(var(--scale-factor)*496.87px); font-size: calc(var(--scale-...
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Abstract
Introduction
Transfusion medicine promotes the safety of blood transfusions by rigorously testing to eliminate risks of infection and hemolytic. The efficacy (to correct ...
Abstract A05: Deep immunofluorescence imaging of solvent-cleared mouse mammary glands
Abstract A05: Deep immunofluorescence imaging of solvent-cleared mouse mammary glands
Abstract
We seek to trace the progression of epithelial lesions originating from Lgr5+ cells in mouse mammary glands using the 3DISCO protocol for solvent-cleared ti...
KEDUDUKAN AHLI BAHASA DALAM PEMBUKTIAN PERKARA PENCEMARAN NAMA BAIK (STUDI PUTUSAN NOMOR: 47/PID.SUS/2019/PN. MGT)
KEDUDUKAN AHLI BAHASA DALAM PEMBUKTIAN PERKARA PENCEMARAN NAMA BAIK (STUDI PUTUSAN NOMOR: 47/PID.SUS/2019/PN. MGT)
<em><span id="page3R_mcid52" class="markedContent"><span style="left: calc(var(--scale-factor)*125.30px); top: calc(var(--scale-factor)*539.11px); font-size: calc(va...
An entire functional mammary gland may comprise the progeny from a single cell
An entire functional mammary gland may comprise the progeny from a single cell
ABSTRACT
Any epithelial portion of a normal mouse mammary gland can reproduce an entire functional gland when transplanted into an epithelium-free mammary fat pad. M...
Abstract 4657: Targeting STAT3 for mammary cancer prevention in MMTV/Neu mice employing the antagonist GLG-302
Abstract 4657: Targeting STAT3 for mammary cancer prevention in MMTV/Neu mice employing the antagonist GLG-302
Abstract
GLG-302 (S3I-201, NSC 74859) from the National Cancer nstitute chemical libraries was identified as a STAT3 antagonist using structure-based virtual screeni...

